Komori
Statutory disclosure document8283PALTAC CORPORATIONTrading & Wholesale

Statutory Prior Disclosure Document (Approval of Demand for Sale of Shares, etc. by Special Controlling Shareholder) (MEDIPAL HOLDINGS CORPORATION)

MEDIPAL HOLDINGS CORPORATION demanded that PALTAC’s minority shareholders sell their shares, and PALTAC approved the demand. Consideration is scheduled to be paid to the minority shareholders on 13 August 2026 at ¥6,650 per share.

Worth reading
82Important
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Neutral
Direction inferred from the company’s description.
Scale
6650
¥ per share
Wording
Conditional
How definitive the wording is.

No category-specific facts could be extracted from this document.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

To enhance corporate value by making PALTAC a wholly owned subsidiary of MEDIPAL HOLDINGS CORPORATION and using the two companies’ management resources in an integrated manner to improve demand visibility, logistics, and data integration, and strengthen their human resources platform.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Statutory Prior Disclosure Document (Approval of Demand for Sale of Shares, etc. by Special Controlling Shareholder) (MEDIPAL HOLDINGS CORPORATION) | PALTAC CORPORATION (8283) timely disclosure | Komori